These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7036146)

  • 21. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration.
    Langenecker SA; Felfernig M; Werba A; Mueller CM; Chiari A; Zimpfer M
    Crit Care Med; 1994 Nov; 22(11):1774-81. PubMed ID: 7956281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased plasma-6-oxo-PGF1-alpha but normal PGI2 half-life in patients with maxillo-facial tumors.
    Porteder H; Matejka M; Kment G; Nell A; Sinzinger H
    Prog Clin Biol Res; 1987; 242():123-9. PubMed ID: 3313409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prostacyclin as a protective factor for blood vessels].
    Leithner C; Sinzinger H; Silberbauer K
    Fortschr Med; 1980 Dec; 98(47-48):1845-9. PubMed ID: 7011923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased platelet sensitivity to prostacyclin (epoprostenol) during hemodialysis.
    Kristensen SD; Knudsen F; Nielsen AH; Ring T
    Clin Nephrol; 1984 Apr; 21(4):230-4. PubMed ID: 6375926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased release of prostacyclin-like activity from rat aorta by plasma from patients with hepatic or renal failure.
    Chamone DA; Van Hoof A; Vermylen J
    Arq Gastroenterol; 1987; 24(1):16-9. PubMed ID: 3329903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of prostacyclin, 6-keto-PGF1 alpha PGF2 alpha and 15[S]15-methyl-PGF2 alpha on platelet aggregation in vitro.
    Marmo E; Somma A; Ottavo R; Vairo G; Spaziante G; DiMezza F; Paone G
    J Med; 1981; 12(2-3):97-108. PubMed ID: 7024451
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of ultrafiltrates in plasma from patients with chronic uremia on platelet aggregation].
    Myśliwiec M; Popławski A; Soszka J
    Pol Tyg Lek; 1991 Jan 21-28; 46(4-5):76-8. PubMed ID: 1845699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of platelet aggregation, thromboxane A2 and prostacyclin in central aortic and coronary sinus blood in ischemic heart disease.
    Narain VS; Bhargava B; Chandra N; Puri VK; Hasan M
    Indian Heart J; 1994; 46(4):149-52. PubMed ID: 7875701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release of a prostacyclin-like substance into the circulation of dogs by intravenous adenosine 5'-diphosphate.
    Hemker DP; Shebuski RJ; Aiken JW
    J Pharmacol Exp Ther; 1980 Feb; 212(2):246-52. PubMed ID: 6985960
    [No Abstract]   [Full Text] [Related]  

  • 30. Prostacyclin in haemodialysis and charcoal haemoperfusion.
    Weston MJ
    Contrib Nephrol; 1983; 36():68-72. PubMed ID: 6340952
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of prostacyclin in the response of cerebral blood flow to CO2.
    Uyama O; Nagatsuka K; Fukunaga R; Kusunoki M; Takano T; Yoneda S; Kimura K; Abe H
    Brain Res; 1983 Jan; 259(2):344-7. PubMed ID: 6402270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin, prostacyclin and post-occlusive reactive hyperaemia in man.
    Tooke JE; Menys VC; Tindall H; Feely M; Davies JA
    Prostaglandins Leukot Med; 1982 Oct; 9(4):379-85. PubMed ID: 6757966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased plasma levels of 6-oxo-prostaglandin F1 alpha, a stable metabolite of prostacyclin, in acute kidney transplant rejection.
    Leithner C; Sinzinger H; Peskar BA
    Prostaglandins Med; 1981 Jul; 7(1):15-8. PubMed ID: 7025069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet activation in clinical haemodialysis: LMWH as a major contributor to bio-incompatibility?
    Gritters M; Borgdorff P; Grooteman MP; Schoorl M; Schoorl M; Bartels PC; Tangelder GJ; Nubé MJ
    Nephrol Dial Transplant; 2008 Sep; 23(9):2911-7. PubMed ID: 18364368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostacyclin substitution for heparin in long-term hemodialysis.
    Smith MC; Danviriyasup K; Crow JW; Cato AE; Park GD; Hassid A; Dunn MJ
    Am J Med; 1982 Nov; 73(5):669-78. PubMed ID: 6753575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prostacyclin synthesis-stimulating plasma factor in different age groups].
    Leithner C; Kefalides A; Hoche C; Sinzinger H
    Aktuelle Gerontol; 1982 Nov; 12(6):217-9. PubMed ID: 6130715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostacyclin is not a circulating hormone in man.
    Blair IA; Barrow SE; Waddell KA; Lewis PJ; Dollery CT
    Prostaglandins; 1982 Apr; 23(4):579-89. PubMed ID: 7051184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Honokiol inhibits arterial thrombosis through endothelial cell protection and stimulation of prostacyclin.
    Hu H; Zhang XX; Wang YY; Chen SZ
    Acta Pharmacol Sin; 2005 Sep; 26(9):1063-8. PubMed ID: 16115372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.